Normal cells show a limited lifespan in culture and the phenotype of cellular senescence. Tumors and tumor cell lines have typically overcome this form of growth suppression and grow continuously as immortal cell lines in culture. We have exploited the DNA virus SV40 to study the mechanism by which human ®broblasts overcome senescence and become immortal. Multiple steps have now been identi®ed, including inactivation of cellular growth suppressors through direct interaction with SV40 large T antigen and through mutation of a gene on chromosome 6 (designated SEN6). In this study, we sublocalize the site of SEN6 to 6q26-27 based on molecular genetic analysis. Twelve SV40-immortalized ®broblast cell lines share a deletion in this area based on assessment for loss of heterozygostiy (LOH) for seven informative markers on 6q. Two immortal cell lines (AR5 and HALneo) appeared to have retained separate single copies of chromosome 6 despite the fact that they are both derived from the same preimmortal SV40-transformant and should share the same mutated allele of SEN6 (Hubbard-Smith et al., 1992) . Detailed analysis by polymerase chain reaction, restriction fragment length polymorphism and¯uorescence in situ hybridization shows, however, that although they dier for 17 markers from the centromere to 6q26, they share AR5 derived sequences (eight markers) distal to 6q26 including the minimal deletion region, further supporting the assignment of SEN6 to this region. Since human tumors including non-Hodgkins lymphoma, mammary carcinoma and ovarian carcinoma show LOH in 6q26-27, inactivation of SEN6 may be responsible for immortalization of these tumors as well.
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Introduction
Carcinogenesis is a multi-step process. Molecular genetic analysis of human tumors has identi®ed diverse mechanisms including combinations of activation of proto-oncogenes, inactivation of growth suppressors and altered activity of other eectors of cellular proliferation inter alia (Vogelstein and Kinzler, 1993) . Multiple changes in chromosome structure and/ or gene function have generally occurred by the time that the clinical tumor can be investigated. In some tumors, such as those of the colorectum, it has been possible to isolate tumors at dierent stages of carcinogenesis and thereby develop a model of sequential gene alteration (Fearon and Vogelstein, 1990) . However, when mutations in genes that are observed in a wide range of tumors such as p53 are studied, mutations are seen relatively late in colorectal tumors (Fearon and Vogelstein, 1990 ) but occur early in another type of tumor (e.g. Barrett's epithelium, the premalignant precursor of esophageal adenocarcinoma) (Casson et al., 1991) . An alternative approach would be to focus on the molecular basis of a particular step in carcinogenesis. Immortalization is such an example.
Somatic cells such as ®broblasts of humans and other species have a limited lifespan in culture and undergo a terminal growth arrest (Hay¯ick, 1965) . This phenotype of senescence has been extensively studied as a model for aging at the cellular level (Campisi, 1996) . On the other hand, human tumors do not commonly show senescent behavior but rather have an inde®nite lifespan or are immortal when introduced into cell culture (Stamps et al., 1992) . Hence, one might also consider senescence to be a mechanism of tumor suppression (Sager, 1989) . Genetic studies have shown that the immortal phenotype is recessive in cell hybrids (Pereira-Smith and Smith, 1983) and that human tumors can be assigned to a limited number of complementation groups by pairwise cell fusion analysis of cell lines (Pereira-Smith and Smith, 1988; Duncan et al., 1993) . Members of four complementation groups (A±D) have been con®rmed to contain unique alterations since distinct individual normal human chromosomes can suppress cell growth in representative cell lines (Ning et al., 1991; Ogata et al., 1993; Sagawara et al., 1990; Sandhu et al., 1994) . Although it has been dicult to determine precisely when immortalization occurs in vivo; it appears most likely to be a stage in tumor progression. For example, the ability to recover immortal cells in culture correlates with the size of human colon adenomas, suggesting that prior events need to occur (Paraskeva et al., 1989) . In addition, continuous proliferation as immortal cells requires stablization of the telomeric sequences at the ends of chromosomes. One mechanism commonly observed in human tumors involves the activation of the enzyme telomerase (Kim et al., 1994) . A high level of telomerase activity correlates with advanced stages of neuroblastomas in humans (Hiyama et al., 1995) and tumor progression in the mouse (Blasco et al., 1996) .
We have been studying the interaction of the DNA tumor virus SV40 with human ®broblasts as a model system for determining the molecular basis for immortalization (Ozer et al., 1996) . We (Radna et al., 1989) and others have found that it is a multistep process, consistent with the observation that normal human ®broblasts rarely, if ever, spontaneously become immortal (McCormick and Maher, 1988) . It is dependent on continuous function of the SV40 encoded large T antigen, which is mediated in large part by its inhibitory eects on the growth suppressors pRB and p53 (Resnick-Silverman et al., 1991; Shay et al., 1991) . Expression of large T antigen is, however, insucient to ensure immortalization of human ®broblasts. Rather such SV40-transformed cells (SV/HF) have an extended lifespan and only a rare pre-immortal SV/HF becomes immortal (Neufeld et al., 1987; Shay and Wright, 1989) . Sequences on the long arm of chromosome 6 have been speci®cally associated with immortalization of such SV/HF. First, immortal SV/HF show karyotypic changes involving 6q when matched sets of preimmortal and immortal SV/HF are compared (HubbardSmith et al., 1992; Ray and Kraemer, 1992; Hoschir et al., 1992) . Secondly, we have shown that introduction of a normal chromosome 6 by microcell-mediated chromosome transfer suppresses growth of immortal SV/HF and induces a senescence-like appearance (Sandhu et al., 1994) . We have proposed that genetic changes in a gene designated as SEN6 is an essential step for immortalization of these SV/HF. In this paper, we have undertaken a detailed examination of 6q in immortal SV/HF independently isolated in several laboratories in order to further sublocalize SEN6. We have found a common minimal deleted region involving the distal region of chromosome 6, i.e. 6q26-27. Since this region has also been implicated as the site of tumor suppressors for several human tumors, it is possible that SEN6 is also involved in immortalization of those tumors as well.
Results

Characterization of SV40-immortalized cell lines
Our earlier studies demonstrated loss of function of a gene on the long arm of chromosome 6, at or distal to 6q21, to be associated speci®cally with immortalization of SV40-transformed human ®broblasts (HubbardSmith et al., 1992; Ray and Kraemer, 1992) . Such studies relied extensively on karyotypic analyses. To de®ne a more precise position of the SEN6 gene, we examined a collection of SV40-transformed immortal human ®broblast cell lines with a set of polymorphic markers spanning dierent regions of 6q. These included cell lines generated in three dierent normal human ®broblast cell strains: HS74, fetal bone marrow ®broblasts; HSF43, newborn foreskin ®broblasts, and IMR 90, fetal lung ®broblasts. The data are summarized in Table 1 . They con®rm the prior studies with HS74 and HSF43 derived cell lines in that several show extensive loss of heterozygosity (LOH) of all or parts of 6q, consistent with the previous cytogenetic data. Initial studies utilized markers dispersed throughout 6q (D6S300 or D6S254, D6S87, ESR and TBP). Some cell lines showed no LOH for any of the markers (e.g. SVtsA/HF-CH2, SV3-4, E10, SW26) but the great majority showed loss of part or all of 6q. The results in some cases (e.g. SV/HF-5/39, SV.RNS/HF-1, CT10-2, E8) indicated LOH more centromeric than 6q21, based on LOH for D6S300 at 6q14. On the other hand, some immortal cell lines showed much more limited LOH, e.g. no LOH for D6S300 or D6S87 at 6q22-23 but LOH for ESR at 6q25.1 (e.g. CT10-2A) or TBP at 6q27 (e.g. SW13). We therefore examined further some of the cell lines for the region at or distal to 6q25 with D6S255 at 6q25.2, and D6S264 as well as D6S281 at 6q26-6q27 in an eort to delineate a common minimum deletion region. The locus for TBP is the most telomeric marker available for 6q (Purrello et al., 1994) . In the case of SW13 there is a deletion distal to ESR since more proximal markers at 6q13 (D6S254) and D6S87 are present but not D6S264 or TBP. A break appears to be in the vicinity of 6q25.1 since D6S253 and D6S305 (both at 6q25.2) as well as IGF2R (6q26) (Rao et al., 1994 ) also show LOH (data not shown). Examination of CT10-2A served to further limit the region of shared LOH; for example, the presence of D6S281 and TBP in CT10-2A indicates that the distal region of 6q was not always lost.
The results for 12 of the cell lines are summarized diagrammatically in Figure 1 which includes two inferences. First, in those cases in which karyotypic data indicate the presence of a rearranged chromosome 6, persistence of the short arm is assumed (in the event that FTHP1 was not assessed) and deletions including D6S300 are drawn to occur at 6q12-13 (i.e. between the centromere and 6q14). Secondly, deletions are considered to extend continuously toward the telomeric end in the absence of additional information, although it is recognised that multiple interstitial rearrangements may be present. Those cell lines which showed no LOH for the alleles tested are not included in Figure 1 . Multiple areas of deletion are evident and indeed there is progressive appearance of areas of LOH when a single immortal cell line SV/HF-5/39 is analysed after extensive blind passage in culture (SV/HF-39 is at passage 54) as compared to a subclone isolated from the cell line at earlier passage (cl 39neo). Altogether, the data are most consistent with a minimal deleted region within 6q26-27, rather than at 6q21 indicated in the previously published studies.
Analysis of HALneo
This conclusion is further supported by an analysis of the cell line HALneo. We had previously reported that the transformant SVtsA/HF-A generated immortalized derivatives at a high frequency (Hubbard-Smith et al., 1992) . In that study, we described two cloned sublines isolated from this transformant at dierent times in its lifespan. AR5 was isolated as a clone after only relatively brief passage of the transformant in culture when the predominant population of SVtsA/HF-A was not immortal (i.e. population doubling level (PDL) 58 and corresponding to two passages after the cells had been expanded from a single morphologically transformed focus to mass culture). HAL, on the other hand, was isolated after 40 passages (greater than 150 PDL) when all the cells in the population had become immortal. That study showed that both AR5 and HAL showed loss of one copy of chromosome 6 based on analyses of karyotype and DNA sequences using quantitative Southern blot analysis (for c-myb, ros and mas) and polymerase chain reaction (PCR) for Table 1 and text. Cell lines are in the same order as in Table 1 , except that those cell lines which showed no LOH are omitted. LOH is indicated by solid lines. In cell lines for which no information is available on the status of 6p, those sequences are indicated with a dashed line. The minimum deletion region is identi®ed by the boxed segment in 6q26-27 D6S87. We would therefore expect that both AR5 and HAL became immortal due to a common mutational event in the remaining allele of the locus on chromosome 6, i.e. a mutation in SEN6. On the other hand, we observed that although both showed LOH for D6S87, they retained dierent alleles at that locus. In view of our conclusion that the minimum region deleted in SV40-immortalized cells is distal to D6S87, we tested the hypothesis that HAL had undergone a further rearrangement such that the region corresponding to 6q26-27 (the presumptive site of SEN6) was in fact shared with that present in AR5. HALneo, a subclone of HAL, was chosen for detailed study since it had been used in growth suppression tests (Sandhu et al., 1994) . Molecular analysis with a variety of polymorphic markers was used to determine whether AR5 and HALneo each retain a dierent copy of chromosome 6 of those present in HS74 (as shown in Table 2 ) and the preimmortal transformant SVtsA/HF-A (data not shown). The independent immortal cell line SV/HF-5/ 39 which shows extensive LOH of 6q at this passage is provided for comparison of alleles for the polymorphic markers as it retains an intact copy of the parental chromosome 6 which is lost in AR5. The data clearly show that HALneo contains numerous alleles characteristic of the parental chromosome other than the one retained in AR5 as suggested by the initial D6S87 data. These loci involve 6p and virtually all of the long arm extending to 6q26. Although several of the markers (e.g. those available from Research Genetics) were not ordered within 6q24-26, they are consistent with those which are mapped more precisely. However, alleles at multiple loci which map distal to 6q26 are shared between HALneo and AR5. These include D6S132, D6S281 and TBP. An example of the restriction fragment length polymorphism (RFLP) marker D6S132 (CEB3) is shown in Figure  2a . Unexpectedly, some markers, such as D6S133 (CEB4), show the presence of both alleles in HALneo as shown in Figure 2b . This was also observed with several other markers including D6S264 (see also  Table 1 ), indicating the persistence of sequences within 6q26-27 from both copies of chromosome 6. Hence the putative region involving the SEN6 gene based on the minimal deletion analysis (i.e. at or distal to 6q26) is shared between HALneo and AR5. We have examined further the region involving the rearrangement in HALneo. This region of persistent heterozygosity in HALneo could be on the same chromosome 6 or be due to a translocation of sequences involving 6q26-qter derived from the chromosome retained in AR5. We therefore performed¯uorescence in situ hybridization (FISH) analysis on HALneo using a whole chromosome 6-speci®c probe as shown in Figure 3a . It is evident that HALneo cells contain a large submetacentric chromosome consistent with virtually all (or all) of chromosome 6 and a small chromosome containing a region of chromosome 6 on one arm. Hybridization with a chromosome 6-speci®c centromeric probe veri®ed that the large chromosome is chromosome 6 (designated 6q*) and the small chromosome is not (Figure 3b and c) . To test whether the translocated sequences contained sequences from 6q26-27, we performed FISH analysis with the cosmid clones CEB3, CEB4, and CEB26 as probes (Vergnaud et al., 1991) . As expected, CEB4, for which both alleles of D6S133 were present, hybridized to both chromosomes (Figure 3b) . In contrast CEB3 which detects only the allele characteristic of AR5 in HALneo hybridized only to the small chromosome (Figure 3c) , as did CEB26 (data not shown). As expected, FISH analysis con®rms two normal-appearing copies of chromosome 6 in HS74 and only intact chromosome(s) 6 in AR5 (data not shown). These results with HALneo therefore demonstrate that there is a deletion on chromosome 6 and a translocation involving 6q26-27 which contains sequences present in the single copy of chromosome 6 in AR5.
To con®rm this interpretation and as a prelude to identify the ends of this translocated fragment, we have separated the respective chromosome 6 sequences in HALneo6mouse cell hybrids. Hybrid clones were screened with D6S300 and D6S264 which are polymorphic for the two copies of chromosome 6 present in HS74 and thus distinguish those sequences in HALneo. DNA from hybrids with 6q* should demonstrate a single allele for both markers (Type I hybrid). DNA from hybrids which retain only the translocated chromosome should show the allele of D6S264 present in AR5, but no allele of D6S300 (Type II hybrid). Such hybrid clones can then be screened by PCR with other primers which detect either polymorphism or non-polymorphism. Hybrids of each class were identi®ed; several representative examples give results consistent with the FISH analysis in Figure 3 and con®rm that sequences from 6q26-27 with alleles characteristic of AR5 are present in concert in the D6S300-negative, D6S264-positive (B allele) DNA. As shown in Table 3 , such class II hybrids contain D6S392, D6S396, D6S1008, D6S281, TBP. On the other hand, allelic markers expected for 6q*, which are shared between HALneo and SV/HF-5/39, are present in the Type I hybrid but not in the Type II hybrid.
In summary, SV40-transformed immortal cells show deletions in the region of 6q26-27. In addition, HALneo has undergone a rearrangement in that region. It has retained sequences from the same region from the chromosome determined to contain a mutated SEN6 locus and lost those corresponding to the nonmutated SEN6. These results thus further support the model that immortalization of human ®broblasts mediated by SV40 involves LOH of the distal region of chromosome 6, consistent with inactivation of a growth suppressor gene at that site.
Discussion
Human diploid ®broblasts show a limited lifespan in culture and undergo growth arrest due to cellular senescence. Introduction of the gene for SV40 large T antigen transiently overcomes senescence through its ability to interfere with the growth suppressors pRB and p53. However, such SV40-transformed (preimmortal) cells nonetheless die after a period of extended lifespan (Neufeld et al., 1987; Ray and Kraemer, 1992) . Permanent reversal of senescence requires one or more cellular mutations as well as persistent expression of large T antigen (Radna et al., 1989; Wright et al., 1989) . Two of our laboratories have previously shown that preimmortal cells undergo a rearrangement involving the long arm of chromosome 6 upon immortalization. We have each proposed that mutation and chromosome loss result in loss of expression of a growth suppressor. Since introduction of a wildtype copy of chromosome 6 (or 6q) results in suppression of growth and appearance of a senescence-like phenotype, we have proposed that a gene which mediates senescence is involved and we have 
termed this locus SEN6. In this paper, we extend the previous ®ndings and identify a region of chromosome 6 which is aected in a manner consistent with SEN6. Our assessment is based on deletion analysis of multiple independent cell lines and a detailed examination of HALneo which has undergone rearrangements involving 6q. All the results generated through multiple approaches involving PCR, RFLP and FISH analyses indicate that a common aected region is at 6q26-27, most likely between D6S133 and D6S281. The region centromeric to D6S133 is excluded not only because of the absence of consistent LOH in the set of immortal SV/HF but also because HALneo and AR5 have dierent chromosome-speci®c alleles through this locus (see Table 2 ), yet they are expected to have a mutation in the same allele of SEN6. The telomeric border of the region of LOH is proximal to D6S281 as de®ned by the presence of both alleles at this locus (and TBP) in CT10-2A. This conclusion does not, however, preclude the existence of more than one growth suppressor on chromosome 6, even within 6q26-27. Rather it emphasizes that one of these loci, i.e. SEN6, is involved in a particular stage of growth regulation, namely immortalization, and that such a locus is in this region. One might reasonably expect that human tumors would also be defective in SEN6 since many tumors are immortal. In fact chromosome 6 is among the most frequently rearranged chromosome among human cancers (as reviewed in Mitelman, 1991; Teyssier and Ferre, 1992) . More speci®cally, LOH involving 6q26-27 has been reported for non-Hodgkins lymphoma (Gaidano et al., 1992; Ot et al., 1993; Menasce et al., 1994) , ovarian epithelial tumors (Saha et al., 1995; Foulkes et al., 1993; Saito et al., 1992a; Wan et al., 1994) and mammary tumors (Devilee et al., 1991; Orphanos et al., 1995) , although no gene has yet been identi®ed as responsible for any of these tumors. Since more than one region on chromosome 6 has been found to have LOH in many of these studies and growth suppression by microcell-mediated chromosome transfer has been shown to involve 6q14-21 for ovarian tumor cells (Sandhu et al., 1996) and 6q25-26 for the breast tumor cell line MCF-7 (Negrini et al., 1994) , multiple growth suppressors may be present on 6q. Additional loci may also be aected in SV40-immortalized cells as more extensive LOH on chromosome 6 is evident on prolonged passage, as shown for derivatives of SV/HF-5/39 in this study. Karyotypic analyses of SV/HF-5/39 have also been consistent with a mixed population of rearrangements involving 6q (Neufeld et al., 1987; Patsalis, unpublished data) . Mutations involving multiple loci aecting cell proliferation might be expected to be selected for by passage of immortal SV/HF under conventional culture conditions as re¯ected in increased eciency of colony formation and shorter generation times (Neufeld et al., 1987) , accumulation of chromosome rearrangements (Neufeld et al., 1987; Hubbard-Smith et al., 1992) and progressive lengthening of telomeric sequences (Small et al., 1996) . The function of SEN6 is unknown. Although alterations in gene expression have been observed in SV40-transformed cells, it is more likely that they are secondary eectors rather than SEN6 itself since these genes have not been found to map to chromosome 6. These include decreased activity of cGMP-dependent protein kinases (Fujii et al., 1995) and other dierences in gene expression upon immortalization (Imai et al., 1994; Ozer et al., 1996; Pardinas et al., manuscript in preparation) . On the other hand, a limited number of genes consistent with eects on cell proliferation have been mapped elsewhere on chromosome 6. These include the cyclin-dependent kinase inhibitor p21 (or sdi) which is overexpressed in senescent cells and is located on the short arm of chromosome 6 (Noda et al., 1994) , SOD-2 (at 6q25.2) which has been shown to inhibit tumorigenesis when overexpressed in melanoma cells (Church et al., 1993) and has been reported to show reduced expression (together with catalase) in SV40-transformed immortal cells (Bravard et al., 1992) , and the transcription factor c-myb (6q23) which is atypically expressed in melanoma cells (Hijiya et al., 1994) and some but not all SV/HF (Hubbard-Smith et al., 1992 and unpublished data) . These may contribute to the further alterations in sequences on chromosome 6 seen in many of the cell lines in this study. These observations emphasize the importance of being able to examine immortal cells early in cell culture in order to assess the relative importance of dierent growth suppressors in immortalization.
Immortalization of human tumors and cell lines in culture is due to a limited number of genetic alterations as Pereira-Smith and Smith (1988) reported that 20 tumors could be categorized into four complementation groups (A±D). Since many SV40-immortalized cell lines have been shown to fall into complementation group A (Pereira-Smith and Smith, 1988), they share a chromosome 6 rearrangement and they are suppressed by introduction of a normal chromosome 6, it would appear that the group A gene is on chromosome 6, i.e. SEN6. HALneo and SV/HF-5/39, two of the cell lines used in this study, share this pattern. They harbor independent mutations since each was generated from a dierent transformant and each retains a dierent parental chromosome 6 for sequences in 6q26-27 based on the linkage analysis of polymorphic alleles, yet both are suppressed in microcell-mediated cell fusion with chromosome 6 but not other chromosomes. It should also be noted that the results in this study are not necessarily contradictory with previous proposals that SEN6 is near 6q21 (Hubbard-Smith et al., 1992; Ray and Kraemer, 1992; Hoschir et al., 1992) . Those studies relied on Giemsa staining and did not assess small translocations, as indeed is present in HALneo. In addition, even deletions involving sequences proximal to 6q21 may be overlooked due to breakage and addition of telomeric and other sequences derived from other chromosomes. Such phenomena have been reported by Meltzer et al. (1993) . In fact, immortal SVtsA/HF-A at early passage shows a deletion which appears to involve 6q21 but actually is at 6q14 (Hubbard-Smith et al., 1992; Patsalis et al., 1995) with the additional translocated sequences derived from another chromosome, such that it fortuitously appears as 6q21. The steps involved in the rearrangements responsible for HALneo are not clear and any interpretation is complicated by the relatively long passage history of HALneo. In any case, the rearrangement as de®ned by the presence of both alleles of the polymorphic marker D6S264 and D6S133 occurred prior to the isolation of HAL since several independent clones isolated at the same time (Radna and Ozer, unpublished data) also show both alleles of these markers (data not shown). It is possible that SV40 large T antigen facilitates such rearrangements. For example, it has recently been found that wild type p53 appears to inhibit homologous recombinantion, an eect which is blocked through binding of p53 by large T antigen (Wiesmuller et al., 1996) . In addition, SV40 transformed cells are somewhat unusual in that stabilization of telomeres often occurs in immortal cells without reactivation of telomerase (Bryan et al., 1995; Small et al., 1996) in contrast to many human tumors. AR5 has telomerase activity but SV/HF-5/39 does not; both cell lines have stabililized their telomeric sequences. The mechanism is not yet understood but a recombinational mechanism has been proposed (Bryan et al., 1995) based on that described in yeast (Wang and Zakian, 1990; Lundblad and Blackburn, 1993) .
In conclusion, a series of SV40-transformed immortal ®broblast cell lines show loss of sequences in 6q26-27, de®ning a minimum deletion between D6S133 and D6S281, consistent with loss of function of a growth suppressor. We predict that this gene SEN6, although expressed in normal ®broblasts, is responsible at least in part for cellular senescence. Furthermore, we expect that its reexpression will inhibit cell proliferation of other immortal tumor cell lines, i.e. those which show evidence of LOH consistent with SEN6 and/or those which do not complement the immortal phenotype in cell hybrids with SV/HF-5/39 (`clone 39') and other members of the A group reported by Pereira-Smith and Smith (1988) . Current eorts are directed to clone the sequences in 6q26-27 encoding SEN6 to test this hypothesis.
Materials and methods
Cell lines and culture conditions SV40-transformed cell lines were obtained from the laboratories in which they were originally isolated and cultured as previously described (Hubbard-Smith et al., 1992) . HS74 and its immortal SV/HF are described as follows: AR5 (Radna et al., 1989) , HALneo (HubbardSmith et al., 1992; Sandhu et al., 1994; and SV/HF-5/39 (Neufeld et al., 1987) . cl 39neo is a derivative of early passage SV/HF-5/39 which was isolated following transfection with pRSVneo. SVtsA/HF-CH2 is an immortal derivative of SVtsA/HF-C transformed with origindefective SV40 DNA encoding a temperature-sensitive large T antigen (pSVtsA58). SV.RNS/HF-1 is an immortal derivative of SV.RNS/HF transformed with a construct (pRNS-1) containing an origin-defective SV40 genome ligated to pRSVneo (Litzkas et al., 1984) . HSF43 and its immortal SV/HF are described as follows: CT10-2, CT10-2A, CT-10-2B, CT10-2C, CT10-12, SV3-4, E8, E10, E17 (Ray and Kraemer, 1992) . IMR90 and its immortal SV/ HF, SW13 and SW26, are described in Shay and Wright (1989) .
DNA probes and primers
Primers for polymorphic dinucleotide repeat markers D6S87 (Weber et al., 1990) , ESR (Del Senno et al., 1993) , D6S281 (Gyapay et al., 1994) and for TBP (Rosen et al., 1995) were synthesized in the Molecular Resource Facility at New Jersey Medical School on an ABI 392 synthesizer. Other primers were purchased from Research Genetics Inc. (Huntsville, AL) (Gyapay et al., 1994) .
DNA analysis
DNA was puri®ed and analysed by PCR (dinucleotide or trinucleotide repeats) or Southern blot (RFLP analysis) according to standard procedures as described in HubbardSmith et al. (1992) with minor modi®cation as determined in the respective laboratories. In some cases, PCR reaction products could be analysed directly on 4% agarose gels and visualized after staining by ethidium bromide. These include the trinucleotide repeat in the coding sequences for TBP and microsatellite repeats for D6S264, D6S300, D6S310, D6S311, D6S363, D6S392, D6S393, D6S437, D6S473 and D6S494. RFLP analysis with cosmid probes included addition of sheared human placental DNA (Sigma) to block hybridization to repetitive sequences.
The cosmids CEB3 (D6S132), CEB4 (D6S133) and CEB26 were obtained from Vergnaud et al. (1991) and propagated as previously described. In the case of CEB4, a 0.7 kb PvuII fragment, free of repetitive sequences and derived from a 3.2 kb subclone (pSHK-1), was used for RFLP analysis.
Fluorescence in situ hybridization
Whole chromosome 6-speci®c painting probe (Spectrum Green TM WCP6) and chromosome 6-speci®c centromeric probe (Spectrum CEP TM 6 Green) labeled with FITC were obtained from Imagenetics. Cosmid probes were labeled with biotin-14-dATP using BioNick kit (GIBCO-BRL) according to the supplier. The cosmid and centromeric probes were resuspended in 10 ml of hybridization solution containing 26SSC, 50% formamide, 2 mg sheared salmon sperm DNA, 1 mg Cot-1 DNA (BRL), 10% dextran sulfate, 0.1% Tween 20, 25 mM sodium phosphate, pH 7.0. Metaphase preparation of HS74, AR5 and HALneo were analysed by FISH as described (Trask, 1992; Banga et al., 1996b) .
Cell hybrid isolation
HALneo6 mouse hybrids were generated to separate the chromosomes containing sequences derived from chromosome 6 in HALneo. The procedure is described in detail elsewhere (Banga and Ozer, 1996a) . In brief, HALneo and SV40-transformed SCID (SCSV3hyg) cells were fused and hybrids were selected in G418 plus hygromycin. DNA was prepared from individual clones and screened for appropriate segregants by PCR analysis. An SV40-transformed mouse cell line was used to minimize the likelihood of complementation (i.e. growth suppression) of SEN6 in the event that immortalization in mouse cells involves the homolog of SEN6 (Gualandi et al., 1994) .
